Sanara Medtech vs Xtant Medical Holdings
Xtant Medical Holdings is the larger business, with $134m of revenue in fiscal 2025 against $103m for Sanara Medtech (1.3 times as much). Sanara Medtech grew faster (19.0% against 14.2%). Xtant Medical Holdings kept more of each dollar of sales as profit: a net margin of 3.7% against -36.4%. Xtant Medical Holdings carries less debt relative to equity (55.7% against 790.2%).
| Latest fiscal year | Sanara MedtechSMTI, 2025 | Xtant Medical HoldingsXTNT, 2025 |
|---|---|---|
| Revenue | $103m | $134m |
| Revenue growth | 19.0% | 14.2% |
| Net income | −$37.6m | $5.0m |
| Operating margin | 7.1% | 5.4% |
| Net margin | -36.4% | 3.7% |
| Return on equity | -165.7% | 10.6% |
| Free cash flow | $2.2m | $10.2m |
| Cash | $16.6m | $17.1m |
| Total debt | $46.9m | $28.4m |
| Debt to equity | 790.2% | 55.7% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 108 | 151 |
| Market value | $295m | $40.6m |
| Price vs our value range | — | — |
| Moat score | 34 (Weak) | 38 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |